Column Group LLC - Q3 2021 holdings

$879 Million is the total value of Column Group LLC's 7 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 80.0% .

 Value Shares↓ Weighting
NGM  NGM Biopharmaceuticals Inc$323,626,000
+6.6%
15,396,1160.0%36.81%
-14.3%
NewTenaya Therapeutics, Inc.$194,116,0009,400,290
+100.0%
22.08%
ORIC  ORIC Pharmaceuticals Inc.$99,703,000
+18.2%
4,768,1810.0%11.34%
-5.0%
RVMD  Revolution Medicines Inc$92,083,000
-13.3%
3,347,2450.0%10.48%
-30.3%
NewSurrozen, Inc.$65,477,0009,248,129
+100.0%
7.45%
NeweFFECTOR Therapeutics Inc$60,546,0004,309,329
+100.0%
6.89%
RAPT SellRAPT Therapeutics Inc$43,532,000
-64.8%
1,402,008
-63.9%
4.95%
-71.7%
CNST ExitConstellation Pharmaceuticals Inc.$0-2,626,631
-100.0%
-12.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NGM Biopharmaceuticals Inc12Q3 202352.5%
Revolution Medicines Inc12Q3 202336.3%
RAPT Therapeutics Inc12Q3 202329.6%
ORIC Pharmaceuticals Inc.12Q3 202314.6%
Tenaya Therapeutics, Inc.9Q3 202324.2%
Surrozen, Inc.9Q3 20238.2%
eFFECTOR Therapeutics Inc9Q3 20236.9%
Constellation Pharmaceuticals Inc.3Q2 202112.6%
Nurix Therapeutics Inc2Q1 202116.1%
Gritstone Oncology Inc1Q4 20200.3%

View Column Group LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-07-24
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
42022-05-27
42022-05-25
13F-HR2022-05-16

View Column Group LLC's complete filings history.

Compare quarters

Export Column Group LLC's holdings